Tom Oostrom of the Dutch Kidney Foundation Shares NeXtkidney Updates

The Dutch Kidney Foundation initiated NeXtkidney, a carry-on-sized HD machine, in 2012. Outcomes of the first clinical trial were good, and more trials will take place in France and the Netherlands in 2025. The goal is to get FDA approval to market NeXtkidney in the U.S.

Read the full article » | Posted 02-14-2025

Related Articles

• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
• FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
• Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
• Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026